Your browser doesn't support javascript.
loading
Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy.
Wang, Jiaoli; Hu, Haoran; Du, Haixia; Luo, Man; Cao, Yilan; Xu, Jiaping; Chen, Tianhang; Guo, Yilei; Li, Qixiang; Chen, Wen; Zhang, Yifei; Han, Jin; Wan, Haitong.
Afiliación
  • Wang J; Zhejiang Chinese Medical University, Hangzhou, China.
  • Hu H; Department of Respiratory Medicine, Hangzhou First People's Hospital, Hangzhou, China.
  • Du H; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Luo M; College of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Cao Y; Department of Respiratory Medicine, Hangzhou First People's Hospital, Hangzhou, China.
  • Xu J; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Chen T; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Guo Y; College of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Li Q; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Chen W; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Zhang Y; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Han J; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Wan H; College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Front Pharmacol ; 13: 986640, 2022.
Article en En | MEDLINE | ID: mdl-36052129

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China